Executive Director
Bristol Myers Squibb/Head of Regulated Bioanalysis & Operations
Princeton, New Jersey
Dr. Jim Shen is an Executive Director and the Head of Regulated Bioanalysis Operations in Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis (CPPDB)
department at Bristol-Myers Squibb. Jim received his B.S. in chemistry from the University of Arizona and his Ph.D. in analytical chemistry from the University of Texas at Austin under the direction of Professor Jennifer Brodbelt. For over twenty-five years, Jim has held several leadership positions in the global life sciences industry. Jim is a senior leader with backgrounds and expertise in managing regulated bioanalytical operations, GLP complaint laboratories, and bioanalytical outsourcing processes. Jim has tenured at leading pharmaceutical companies like Schering Plough, Merck, and BMS leading regulated bioanalysis operations. In his professional capacity, Jim has spoken widely in industry forums and led activities at organizations such as AAPS, ASMS, CPSA, EAS, and ACS. Jim is elected Secretary for AAPS bioanalytical community and has deep connections within the regulated bioanalysis community. Jim is also a prolific writer, publishing extensively in various peer reviewed scientific journals.
Advances in Regulated Bioanalytical Strategies Supporting Quantitation of Protein Degraders
Tuesday, October 24, 2023
9:00 AM – 9:30 AM ET
Rapid Fires: The Bioanalytical Lab of the Future 2
Wednesday, October 25, 2023
3:00 PM – 4:00 PM ET